Medical Marijuana Research: Alzheimer's disease
An estimated four million Americans have Alzheimer's dementia - a number that is likely to grow as the country's population ages. Alzheimer's is predicted to affect 1 in 85 people globally by 2050. Typically beginning with memory loss and behavioural changes, Alzheimer's is an incurable progressive disease of the nervous system. Therapies for Alzheimer's are limited to relieving its various symptoms at present.
Alzheimer's disease (AD) is the most ordinary type dementia. There is no exact treatment for the disease yet which actually gets worse as it progresses, eventually leading to death. The disease was first explained by German neuro-pathologist and psychiatrist, Alois Alzheimer, in the year 1906 and the disease was called after his name. Oftentimes the disease is identified in people over the age of 65 and the less common onset of AD can happen even earlier.
The disease progresses in different ways for every person and it consists with many different symptoms. Most of the time, early symptoms are mistaken have something to do with age concerns or evidence of stress. In its early stages, the very usual symptom is having a hard time in recalling recent events. At the time that Alzheimer's disease is assumed, the analysis is mostly confirmed with trials that examine thinking abilities and behaviour and often following a brain scan in case it is available.
As AD develops, symptoms can already include irritability, aggression, confusion, mood swings, long term memory loss, and trouble with language. Eventually, patients often draw back from family and community and when bodily functions reach their weakest; this inevitably leads to their death. The disease is dissimilar for each patient and foreseeing its effect on the patient is as well difficult. The disease usually builds up for an unidentified and varying time before making it completely evident and it can advance unseen for the longest time.
Since the progression and cause of Alzheimer's disease are not really clear, researchers are then challenged to even dig deeper in their studies to help patients cope with the symptoms. Research indicates that the disease is associated with tangles and plaques in the brain. Current treatment only helps with the signs of AD and there are also no existing treatments that reverse or prevent the advancement of the disease. At present, over 1000 clinical tests were conducted and continue to be conducted to solely find solutions in treating the disease or at least relieve symptoms. Among the suggested ways to delay cognitive symptoms are exercise, balanced diet, and mental stimulation. Sometimes, antidepressant medications improve appetites of patients since food refusal, is a natural problem among patients who suffer from Alzheimer's dementia. Treatments diminishing agitation as well as antisocial behaviour in Alzheimer's patients are being welcomed.
There are two major drugs, tacrine (Cognex) and donepeziel (Aricept) which enhance mental functions in a number patients; however, these drugs also do not guarantee to preven progression of AD. In one study having 11 AD patients being treated with oral THC (dronabinol, Marinol) within six weeks which was followed by another six weeks of taking a placebo, researchers found out that that the drug generated weight gain and lessened disturbed behaviour with no threatening side effects.
The information found in this website is for general information purposes only and should not be construed as medical or legal advice. The OMMC Clinic LLC is in no way recommending or advising the use of marijuana nor is it making any medical claims.
Oregon Medical Marijuana Card Application
Once your application is submitted, our certified medical marijuana doctor will review your application and determine your eligibility within 48 hours. We will call you with your results and to schedule your appointment at our closet clinic.
- Apply for Medical Marijuana
- OMMP Card Renewal
- Non-Resident Cards
- Card Process
- Medical Qualifications
- Medical Cannabis Research
- Approved Conditions by state
- Cannabis Pharmaceutical Medicines
- Cannabis Cannabinoid Chemistry
- Cannabis Research Background
- Cannabis Clinical Trails
- Future Cannabis Research
- Multiple Sclerosis Cannabis Research
- Medical Marijuana For Multiple Sclerosis
- Epilepsy Cannabis Research
- Glaucoma Cannabis Research
- Parkinsons Cannabis Research
- Alzheimer's Disease Cannabis Research
- Crohns Disease Cannabis Research
- Cancer Cannabis Research
- Cancer Treatment W/ Cannabis
- Pain Relief Cannabis Research
- Migraine Relief Cannabis Research
- AIDS-HIV Healing Cannabis Research
- Wasting Syndrome Cannabis Research
- Cachexia Cannabis Research
- PTSD Cannabis Research
- Cannabinoid Cell Research
- Nervous System Research
- Immune System Research
- Testing Cannabis Effectiveness
- Using Cannabis Safely
- •Severe pain
- •Severe nausea
- •Muscle spasms
- •Parkinson's disease
- •Multiple Sclerosis
- Marijuana Doctors visit: $175
- OMMP state filing fee: $200
- OMMP filing fee for food stamps: $60
- OMMP filing fee for OHP: $50
- OMMP filing fee if on SSI: $20
Oregon Medical Marijuana Cards
Medical Research Information
Medical Research By Condition
Medical Marijuana Effects
OMMP Card Fees